Cerulean Pharma reported $124.5M in Market Capitalization this March of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adamis Pharmaceuticals ADMP:US 0.08B 0.01B
Agile Therapeutics AGRX:US $ 0.01B 0.01B
Arrowhead Research ARWR:US $ 3.72B 1.14B
Bayer BAYN:GR 55.72B 5.79B
Biocept BIOC:US $ 0.04B 0.02B
Brainstorm Cell Therapeutics BCLI:US $ 0.1B 0.02B
Cerulean Pharma CERU:US $ 0.12B 0.04B
Immunogen IMGN:US $ 0.99B 0.06B
Johnson & Johnson JNJ:US $ 467.1B 1.05B
Macrogenics MGNX:US $ 0.18B 0.36B
Merk MRK:US $ 230.55B 23.1B
Nektar Therapeutics NKTR:US $ 0.71B 0.3B
Perrigo Ordinary Shares PRGO:US 5.46B 0.29B
Pfizer PFE:US $ 294.18B 1.79B
Seattle Genetics SGEN:US $ 32.57B 6.12B
YTE INCY:US $ 16.83B 0.75B